Warning Letter Roundup & Recap – Jan. 16, 2018
Executive Summary
Becton Dickinson received a scathing missive from US FDA that addresses quality systems, Medical Device Reporting and pre-market violations at the firm's Franklin Lakes, NJ, facility. It was the only device-related warning letter released by the agency this week.
You may also be interested in...
BD Handed US FDA Warning Letter In Lead-Test Investigation
The agency letter cites quality systems, Medical Device Reporting and device clearance concerns. It stems from an ongoing investigation into lead tests distributed by Magellan Biosciences that sometimes give faulty results.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.